» Articles » PMID: 24278696

Genome-scale Technology Driven Advances to Research into Normal and Malignant Haematopoiesis

Overview
Publisher Wiley
Specialty Biology
Date 2013 Nov 27
PMID 24278696
Authors
Affiliations
Soon will be listed here.
Abstract

Haematopoiesis or blood development has long served as a model system for adult stem cell biology. Moreover, when combined, the various cancers of the blood represent one of the commonest human malignancies. Large numbers of researchers have therefore dedicated their scientific careers to studying haematopoiesis for more than a century. Throughout this period, many new technologies have first been applied towards the study of blood cells, and the research fields of normal and malignant haematopoiesis have also been some of the earliest adopters of genome-scale technologies. This has resulted in significant new insights with implications ranging from basic biological mechanisms to patient diagnosis and prognosis and also produced lessons likely to be relevant for many other areas of biomedical research. This paper discusses the current state of play for a range of genome-scale applications within haemopoiesis research, including gene expression profiling, ChIP-sequencing, genomewide association analysis, and cancer genome sequencing. A concluding outlook section explores likely future areas of progress as well as potential technological and educational bottlenecks.

References
1.
Nordlund J, Kiialainen A, Karlberg O, Berglund E, Goransson-Kultima H, Sonderkaer M . Digital gene expression profiling of primary acute lymphoblastic leukemia cells. Leukemia. 2011; 26(6):1218-27. PMC: 3377998. DOI: 10.1038/leu.2011.358. View

2.
Basso K, Saito M, Sumazin P, Margolin A, Wang K, Lim W . Integrated biochemical and computational approach identifies BCL6 direct target genes controlling multiple pathways in normal germinal center B cells. Blood. 2009; 115(5):975-84. PMC: 2817639. DOI: 10.1182/blood-2009-06-227017. View

3.
Adams D, Altucci L, Antonarakis S, Ballesteros J, Beck S, Bird A . BLUEPRINT to decode the epigenetic signature written in blood. Nat Biotechnol. 2012; 30(3):224-6. DOI: 10.1038/nbt.2153. View

4.
Bonadies N, Foster S, Chan W, Kvinlaug B, Spensberger D, Dawson M . Genome-wide analysis of transcriptional reprogramming in mouse models of acute myeloid leukaemia. PLoS One. 2011; 6(1):e16330. PMC: 3030562. DOI: 10.1371/journal.pone.0016330. View

5.
Pang W, Price E, Sahoo D, Beerman I, Maloney W, Rossi D . Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age. Proc Natl Acad Sci U S A. 2011; 108(50):20012-7. PMC: 3250139. DOI: 10.1073/pnas.1116110108. View